Brain-derived neurotrophic factor measurements in mouse serum and plasma using a sensitive and specific enzyme-linked immunosorbent assay

This study is about the quantification and validation of BDNF levels in mouse serum and plasma using a sensitive immunoassay. While BDNF levels are readily detectable in human serum, the functional implications of these measurements are unclear as BDNF released from human blood platelets is the main contributor to the serum levels of BDNF. As mouse platelets do not contain BDNF, this confounding factor is absent in the mouse. Accordingly, BDNF levels in mouse serum and plasma were found to be indistinguishable at 9.92 +/- 1.97 pg/mL for serum and 10.58 +/- 2.43 pg/mL for plasma (p = 0.473). These levels are approximately a thousand times lower than those measured in human serum and pre-adsorption with anti-BDNF, but not with anti-NGF or anti-NT3 monoclonal antibodies, markedly reduced the BDNF signal. These results open the possibility to explore the relevance of BDNF levels as a biomarker in accessible body fluids using existing mouse models mimicking human pathological conditions.

Automated summary

This study quantifies and validates the levels of BDNF in mouse serum and plasma using a sensitive immunoassay. The study finds that BDNF levels in mouse serum and plasma are indistinguishable, and are much lower than those in human serum. Pre-adsorption with anti-BDNF effectively reduces the BDNF signal. These findings suggest that BDNF levels can be explored as a biomarker in accessible body fluids using mouse models.